Reference | Settings (Ages) | Matrix | Percentile | Cd | Hg | Mn | Pb |
---|---|---|---|---|---|---|---|
This study | Kinshasa (Ages 3–14) | Blood | P5-P95 (GM) | 0.022–1.112 (0.074) | 0.060–1.161 (0.208) | 6.597–15.740 (9.882) | 35.69–144.50 (71.43) |
Urine | 0.082–1.53 (0.366) | 0.323–1.953 (0.709) | 0.070–1.703 (0.186) | 1.827–18.500 (5.458) | |||
Tuakuila et al. [21] | Kinshasa (Ages 3–14) | Blood | P25-P95 (GM) | 0.09–4.2 (0.14) | 1.3–4.2 (1.7) | – | 45–146 (59) |
Urine | 0.18–1.7 (0.34) | 5.5–19.3 (6.5) | – | 2.9–23.0 (5.7) | |||
Vogel et al. [48] | Germany (Ages 3–13) | Blood | P50-P95 (GM) | 0.06–0.23 (−) | – | – | 9.4–19.9 (9.47) |
Urine | 0.08–0.24 (0.072) | 0.07–0.25 (0.067) | – | – | |||
Burn et al. [55] | Germany (Ages 3–11) | Blood | P50-P95 | 0.40–1.07 | 1.80–3.68 | – | 12.3–21.4 |
Health Canada [46] | Canada (Ages 3–11) | Blood | P10-P95 (GM) | 0.097–0.20 (0.099) | 0.34–1.9 (0.34) | – | 2.6–12.0 (5.0) |
Urine | 0.047–0.28 (0.048) | – | – | – | |||
CDC [62] | USA (Ages 3–11) | Blood | P50-P95 | 0.100–0.220 | 0.262–1.710 | 10.5–17.9 | 6.20–20.02 |
Urine | 0.036–0.148 | 0.241–0.570 | 0.133–0.410 | 0.460–1.19 | |||
SZÚ [63] | Czech Republic (Ages 3–11) | Urine | P50 (GM) | 0.096 (0.096) | 0.28 (0.276) | – | – |
Jeong et al. [64] | Republic of Korea (Ages 3–13) | Blood | P50 | 0.90 | – | – | 14.3 |